title: Tocilizumab treatment for recalcitrant uveitic macular edema.
authors.affiliation: Department of Ophthalmology, Hospital Clinic of Barcelona, Calle Sabino de Arana, 1, 08036, Barcelona, Spain, amadan@clinic.ub.es.
authors.forename: Alfredo
authors.initials: A
authors.lastname: Adán
authors.forename: Victor
authors.initials: V
authors.lastname: Llorenç
authors.forename: Marina
authors.initials: M
authors.lastname: Mesquida
authors.forename: Laura
authors.initials: L
authors.lastname: Pelegrín
mesh_terms: D000284:Administration, Oral; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007262:Infusions, Intravenous; D008269:Macular Edema / Q000188:drug therapy* / Q000209:etiology; D008875:Middle Aged; D015864:Panuveitis / Q000150:complications / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use*; D019947:Receptors, Interleukin-6 / Q000037:antagonists & inhibitors; D041623:Tomography, Optical Coherence; D014792:Visual Acuity
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D005938:Glucocorticoids; D019947:Receptors, Interleukin-6; C502936:tocilizumab; D011241:Prednisone